Related references
Note: Only part of the references are listed.Restoring glutamate receptor signaling in pancreatic alpha cells rescues glucagon responses in type 1 diabetes
Julia K. Panzer et al.
CELL REPORTS (2022)
Glucagon Resistance and Decreased Susceptibility to Diabetes in a Model of Chronic Hyperglucagonemia
Nadejda Bozadjieva Kramer et al.
DIABETES (2021)
Gq signaling in α cells is critical for q maintaining euglycemia
Liu Liu et al.
JCI INSIGHT (2021)
Repositioning Glucagon Action in the Physiology and Pharmacology of Diabetes
Brian Finan et al.
DIABETES (2020)
Glucagon Resistance at the Level of Amino Acid Turnover in Obese Subjects With Hepatic Steatosis
Malte P. Suppli et al.
DIABETES (2020)
Postprandial Aminogenic Insulin and Glucagon Secretion Can Stimulate Glucose Flux in Humans
Teddy Ang et al.
DIABETES (2019)
The Liver-α-Cell Axis and Type 2 Diabetes
Nicolai J. Wewer Albrechtsen et al.
ENDOCRINE REVIEWS (2019)
Glucose intolerance in monosodium glutamate obesity is linked to hyperglucagonemia and insulin resistance in α cells
Thiago R. Araujo et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2019)
Glucagon lowers glycemia when β cells are active
Megan E. Capozzi et al.
JCI INSIGHT (2019)
Hepatic Glucagon Receptor Signaling Enhances Insulin-Stimulated Glucose Disposal in Rodents
Teayoun Kim et al.
DIABETES (2018)
Loss of mTORC1 signaling alters pancreatic α cell mass and impairs glucagon secretion
Nadejda Bozadjieva et al.
JOURNAL OF CLINICAL INVESTIGATION (2017)
Loss of mTORC1 signalling impairs β-cell homeostasis and insulin processing
Manuel Blandino-Rosano et al.
NATURE COMMUNICATIONS (2017)
Overexpression of Kinase-Dead mTOR Impairs Glucose Homeostasis by Regulating Insulin Secretion and Not -Cell Mass
Emilyn U. Alejandro et al.
DIABETES (2017)
Amino Acid Transporter Slc38a5 Controls Glucagon Receptor Inhibition-Induced Pancreatic α Cell Hyperplasia in Mice
Jinrang Kim et al.
CELL METABOLISM (2017)
Interrupted Glucagon Signaling Reveals Hepatic α Cell Axis and Role for L-Glutamine in α Cell Proliferation
E. Danielle Dean et al.
CELL METABOLISM (2017)
Glucagon Couples Hepatic Amino Acid Catabolism to mTOR-Dependent Regulation of α-Cell Mass
Mark J. Solloway et al.
CELL REPORTS (2015)
Insulin Resistance Alters Islet Morphology in Nondiabetic Humans
Teresa Mezza et al.
DIABETES (2014)
Hyperglucagonaemia analysed by glucagon sandwich ELISA: nonspecific interference or truly elevated levels?
Nicolai J. Wewer Albrechtsen et al.
DIABETOLOGIA (2014)
Maternal diet-induced microRNAs and mTOR underlie β cell dysfunction in offspring
Emilyn U. Alejandro et al.
JOURNAL OF CLINICAL INVESTIGATION (2014)
α-Cells are dispensable in postnatal morphogenesis and maturation of mouse pancreatic islets
Chiyo Shiota et al.
AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM (2013)
Liver-Specific Disruption of the Murine Glucagon Receptor Produces α-Cell Hyperplasia Evidence for a Circulating α-Cell Growth Factor
Christine Longuet et al.
DIABETES (2013)
Brainstem Nutrient Sensing in the Nucleus of the Solitary Tract Inhibits Feeding
Clemence Blouet et al.
CELL METABOLISM (2012)
Glucagon regulation of energy metabolism
Kristy M. Heppner et al.
PHYSIOLOGY & BEHAVIOR (2010)
mTOR, AMPK, and GCN2 coordinate the adaptation of hepatic energy metabolic pathways in response to protein intake in the rat
Nattida Chotechuang et al.
AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM (2009)
The role of hypothalamic mammalian target of rapamycin complex 1 signaling in diet-induced obesity
Daniela Cota et al.
JOURNAL OF NEUROSCIENCE (2008)
Liver glyconeogenesis:: a pathway to cope with postprandial amino acid excess in high-protein fed rats?
Dalila Azzout-Marniche et al.
AMERICAN JOURNAL OF PHYSIOLOGY-REGULATORY INTEGRATIVE AND COMPARATIVE PHYSIOLOGY (2007)
Evidence of hepatic glucagon resistance associated with hepatic steatosis: Reversal effect of training
A Charbonneau et al.
INTERNATIONAL JOURNAL OF SPORTS MEDICINE (2005)
Rheb binds and regulates the mTOR kinase
X Long et al.
CURRENT BIOLOGY (2005)
mTOR controls cell cycle progression through its cell growth effectors S6K1 and 4E-BP1/eukaryotic translation initiation factor 4E
DC Fingar et al.
MOLECULAR AND CELLULAR BIOLOGY (2004)
Defective insulin secretion and increased susceptibility to experimental diabetes are induced by reduced Akt activity in pancreatic islet β cells
E Bernal-Mizrachi et al.
JOURNAL OF CLINICAL INVESTIGATION (2004)
Selective β-cell loss and β-cell expansion in patients with type 2 diabetes mellitus in Korea
KH Yoon et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2003)
Lower blood glucose, hyperglucagonemia, and pancreatic α cell hyperplasia in glucagon receptor knockout mice
RW Gelling et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)
Mammalian cell size is controlled by mTOR and its downstream targets S6K1 and 4EBP1/eIF4E
DC Fingar et al.
GENES & DEVELOPMENT (2002)
Islet β cell expression of constitutively active Akt1/PKBα induces striking hypertrophy, hyperplasia, and hyperinsulinemia
E Bernal-Mizrachi et al.
JOURNAL OF CLINICAL INVESTIGATION (2001)
Attenuation of age-related declines in glucagon-mediated signal transduction in rat liver by exercise training
DA Podolin et al.
AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM (2001)
Share Paper
